



| Catalog No. | JN072016 |
|---|---|
| Description |
Pritoxaximab (JN072016) is a research-grade recombinant antibody targeting shiga toxin type 1stx1B. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Escherichia coli |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Chimeric |
| Isotype | IgG1-kappa |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | shiga toxin type 1stx1B |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | Q47641 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | Shigamabs(drugnameforthecombinationofpritoxaximabandsetoxaximab), caStx1, 1351470-16-0 |
| Background | Shiga toxin subunit B (shiga toxin type 1Bstx1B) is a ~9 kDa protein. The B subunit is responsible for the binding of the holotoxin to specific receptors on the target cell surface, such as globotriaosylceramide (Gb3) in human intestinal microvilli. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SEC-HPLC detection for Research Grade Pritoxaximab.

SDS-PAGE for Research Grade Pritoxaximab
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com




+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский